Skip to main content
. 2010 Apr 15;6:179–187. doi: 10.2147/vhrm.s6099

Figure 1.

Figure 1

Rates of death and myocardial infarction in prespecified subgroups at 30 days in the OASIS-6 trial. Reproduced with permission from Yusuf S, Mehta SR, Chrolavicius S, et al. Effects of Fondaparinux, on mortality and reinfarction in patients with acute ST-segment elevation mycardial infarction: the OASIS-6 randomized trial. JAMA. 2006;295(13):1519–1530.16 Copyright © 2006 American Medical Association.